Alzinova: Receives regulatory approval for extension study - Redeye

Redeye leaves a short comment following Alzinova’s announcement of a received approval from regulatory authorities to evaluate a higher dose of the vaccine candidate ALZ-101 in an extension part of the ongoing phase Ib study.

Länk till analysen i sin helhet: https://www.redeye.se/research/978453/alzinova-receives-regulatory-approval-for-extension-study?utm_source=finwire&utm_medium=RSS